IFP Advisors’s Nuvation Bio NUVB Stock Holding History

IFP Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.06K	Buy	1,083 +1	+0.1%	+$6	﹤0.01%	3690
2026 Q2	$6.15K	Sell	1,082 -2,706	-71%	-$13.2K	﹤0.01%	3661
2026 Q1	$16.3K	Buy	3,788 +2,689	+245%	+$15K	﹤0.01%	2887
2025 Q4	$9.8K	Hold	1,099	–	–	﹤0.01%	3075
2025 Q3	$4.07K	Buy	1,099 +884	+411%	+$2.41K	﹤0.01%	3360
2025 Q2	$420	Buy	215 +165	+330%	+$344	﹤0.01%	4483
2025 Q1	$88	Hold	50	–	–	﹤0.01%	3889
2024 Q4	$133	Buy	+50	New	+$129	﹤0.01%	3923

Other funds holding NUVB

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Laurion Capital Management New York $6.21B AUM 32.28% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 38.25% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return

IFP Advisors's NUVB Position: Q3 2026 in Review

IFP Advisors increased its Nuvation Bio (NUVB) stake by 0.09% in Q3 2026, buying an estimated $6 and bringing the position to 1,083 shares worth $6.06K. The position accounts for ﹤0.01% of the portfolio, ranked #3690.

IFP Advisors first reported a position in NUVB in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.3K in Q1 2026. 143 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

IFP Advisors held 1,083 shares of Nuvation Bio worth $6.06K as of Q3 2026.
IFP Advisors bought 1 Nuvation Bio share in Q3 2026, an estimated $6.
Nuvation Bio made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #3690 holding.
IFP Advisors first reported a position in Nuvation Bio in Q4 2024 and has held it in 8 quarters since.
IFP Advisors's Nuvation Bio position peaked at $16.3K in Q1 2026.
143 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.